Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
University of Michigan
Research
Rome's 'dark genome' drug reduces autoimmune markers in mice
Preclinical tests of Rome Therapeutics' drug show that it’s effective in reducing a type of inflammation believed to promote autoimmune disease.
Helen Floersh
Nov 17, 2023 1:03pm
Old seizure drug has new potential in preserving donor hearts
Feb 10, 2023 12:26pm
Machine learning to hone precision meds for cancer backup genes
Sep 29, 2022 3:30pm
Hormone pinpointed that's linked to liver cancer growth in NASH
Aug 15, 2022 5:00pm
Degrading a protein nexus behind prostate cancer
Dec 30, 2021 10:15am
Negative pressure tent for COVID treatment nets FDA emergency OK
Aug 12, 2021 9:40am
